Our community narratives are driven by numbers and valuation.
Using the Buffett Value Calculation with P/E = $46.02, Growth Rate = 39.18%, and EPS ttm = $0.55 (source: FinViz, 12/8/25) - the Estimated Share Price is $79.54 with a Buy Price set at $39.77 or less.Read more
1. Strategic Focus: Data Centers and "Power Banks" 1.1. Transition from "Powered Shell" to "Fully Fitted" Model In the past, SEGRO provided only the building shell and power connection for data centers, leaving the internal equipment (cooling, generators, server racks) to the tenant.Read more
PRME Medicine has just announced the publication of an important article in The New England Journal of Medicine. The article announces success in developing a new treatment using gene editing and stem cell therapy in clinical trials.Read more
I became attracted to this ETF because of it's high percentage of dividends that qualify as long-term, qualified dividends. I don't recall the exact percentage, but it's something in the neighborhood of 62% of dividends being qualified.Read more
Why Halyk Bank Could Be a Hidden Gem for Long-Term Investors If you're looking for a mix of high dividends, strong profits, and big long-term potential, Halyk Bank deserves serious attention. As the largest bank in Kazakhstan, it offers much more than meets the eye—and right now, it looks like a major bargain.Read more
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.Read more
As a speculative investment, Magma Silver could potentially benefit from the breakout in Silver price above the $55 USD threshold. With 3.5 oz of Silver and a bonus 2 grams of gold per metric ton at their Joramina zone of the Ninobamba Project in Peru, Magma is poised to capitalize on the rising price of both Silver and Gold commodities in the near future.Read more
Originally Posted Dec 5 on the Woodworth Contrarian News Page Brought to you by Quinn Millegan & The Woodworth Contrarian Fund A Deep Dive Into Why the Market Is Pricing MGPI for Permanent Decline When Cyclical Recovery Is Lurking in Plain Sight MGP Ingredient’s factories in Atchison, KS & Lawrenceburg, IN - MGP Ingredients Corporate THE SETUP: MEET THE STOCK THAT FELL 75% AND NOBODY NOTICED MGP Ingredients closed at $24.70 yesterday (with a 3–6% increase intraday today). Two years ago—December 4, 2023—it traded at $91.53.Read more
The "Molecular Pencil": Why Beam's Technology is Built to Win The investment thesis in Beam Therapeutics is a long-term, high-conviction bet on a fundamental technological shift in genetic medicine. While first-generation gene editors like CRISPR-Cas9 function as "molecular scissors," they are an inherently disruptive tool.Read more
